Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021

We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation me...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallon, Patrick WG, Horgan, Mary, McAloon, Conor G, Lunn, Peter D, Little, Julian, Beck, Andrew, Bennett, Alexandria, Shaver, Nicole, McConway, Aileen, O’Regan, Rhea, Whelan, Barbara, Connell, Jeff, Lunn, Pete, Mallon, Patrick, Mills, Kingston HG, O’Mahony, Patrick, Prior, Anna-Rose, Smyth, Breda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804664/
https://www.ncbi.nlm.nih.gov/pubmed/35057900
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.3.2101202
_version_ 1784643128198692864
author Mallon, Patrick WG
Horgan, Mary
McAloon, Conor G
Lunn, Peter D
Little, Julian
Beck, Andrew
Bennett, Alexandria
Shaver, Nicole
McConway, Aileen
O’Regan, Rhea
Whelan, Barbara
Horgan, Mary
Connell, Jeff
Lunn, Pete
Mallon, Patrick
Mills, Kingston HG
O’Mahony, Patrick
Prior, Anna-Rose
Smyth, Breda
author_facet Mallon, Patrick WG
Horgan, Mary
McAloon, Conor G
Lunn, Peter D
Little, Julian
Beck, Andrew
Bennett, Alexandria
Shaver, Nicole
McConway, Aileen
O’Regan, Rhea
Whelan, Barbara
Horgan, Mary
Connell, Jeff
Lunn, Pete
Mallon, Patrick
Mills, Kingston HG
O’Mahony, Patrick
Prior, Anna-Rose
Smyth, Breda
author_sort Mallon, Patrick WG
collection PubMed
description We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation measure to reduce transmission of SARS-CoV-2. The tool aims to stratify, in real time, the overall risk of SARS-CoV-2 transmission associated with common activities and events, and this can be matched to an appropriate Ag-RDT testing protocol.
format Online
Article
Text
id pubmed-8804664
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-88046642022-02-24 Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021 Mallon, Patrick WG Horgan, Mary McAloon, Conor G Lunn, Peter D Little, Julian Beck, Andrew Bennett, Alexandria Shaver, Nicole McConway, Aileen O’Regan, Rhea Whelan, Barbara Horgan, Mary Connell, Jeff Lunn, Pete Mallon, Patrick Mills, Kingston HG O’Mahony, Patrick Prior, Anna-Rose Smyth, Breda Euro Surveill Rapid Communication We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation measure to reduce transmission of SARS-CoV-2. The tool aims to stratify, in real time, the overall risk of SARS-CoV-2 transmission associated with common activities and events, and this can be matched to an appropriate Ag-RDT testing protocol. European Centre for Disease Prevention and Control (ECDC) 2022-01-20 /pmc/articles/PMC8804664/ /pubmed/35057900 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.3.2101202 Text en This article is copyright of the authors or their affiliated institutions, 2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Mallon, Patrick WG
Horgan, Mary
McAloon, Conor G
Lunn, Peter D
Little, Julian
Beck, Andrew
Bennett, Alexandria
Shaver, Nicole
McConway, Aileen
O’Regan, Rhea
Whelan, Barbara
Horgan, Mary
Connell, Jeff
Lunn, Pete
Mallon, Patrick
Mills, Kingston HG
O’Mahony, Patrick
Prior, Anna-Rose
Smyth, Breda
Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021
title Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021
title_full Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021
title_fullStr Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021
title_full_unstemmed Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021
title_short Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021
title_sort development of a risk assessment profile tool to determine appropriate use of sars-cov-2 rapid antigen detection tests for different activities and events in ireland, since october 2021
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804664/
https://www.ncbi.nlm.nih.gov/pubmed/35057900
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.3.2101202
work_keys_str_mv AT mallonpatrickwg developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT horganmary developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT mcaloonconorg developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT lunnpeterd developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT littlejulian developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT beckandrew developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT bennettalexandria developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT shavernicole developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT mcconwayaileen developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT oreganrhea developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT whelanbarbara developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT horganmary developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT connelljeff developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT lunnpete developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT mallonpatrick developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT millskingstonhg developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT omahonypatrick developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT priorannarose developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021
AT smythbreda developmentofariskassessmentprofiletooltodetermineappropriateuseofsarscov2rapidantigendetectiontestsfordifferentactivitiesandeventsinirelandsinceoctober2021

Ejemplares similares